Self-Assembled Affibody-PROTAC Nanomedicine Targets Cancer Cells
A new nanomedicine that combines a cancer-seeking protein with a molecular “degrader” has shown targeted activity against HER2-positive tumors in ...
A new nanomedicine that combines a cancer-seeking protein with a molecular “degrader” has shown targeted activity against HER2-positive tumors in ...
The challenge of targeting cancer cells while sparing healthy tissue has long bedeviled oncologists, making the pursuit of precision therapies ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine